Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Empower will be occupying 170,000 square feet of the existing Aurobindo Pharma building at the ... The article Empower ...

Shares of major Indian pharmaceutical companies on Wednesday, including Aurobindo Pharma, Sun Pharmaceutical Industries (Sun ...

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

Novartis has called off the sale of two US generics businesses to India’s Aurobindo Pharma, part of a restructuring ... one in North Carolina and two in New York. The specifics of why the ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, reports successful trial results for BP16, a new drug showing promise ...